INGANNATO, ASSUNTA
 Distribuzione geografica
Continente #
EU - Europa 682
NA - Nord America 573
AS - Asia 188
SA - Sud America 2
OC - Oceania 1
Totale 1.446
Nazione #
US - Stati Uniti d'America 571
RU - Federazione Russa 438
IT - Italia 96
SG - Singapore 74
IE - Irlanda 51
SE - Svezia 49
HK - Hong Kong 47
CN - Cina 31
IN - India 17
DE - Germania 14
JO - Giordania 14
FI - Finlandia 12
GB - Regno Unito 7
CH - Svizzera 4
BE - Belgio 2
BR - Brasile 2
FR - Francia 2
JP - Giappone 2
KR - Corea 2
BG - Bulgaria 1
CA - Canada 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
IL - Israele 1
MK - Macedonia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
Totale 1.446
Città #
Santa Clara 275
Singapore 55
Chandler 53
Dublin 51
Hong Kong 36
Ashburn 27
Florence 23
Mumbai 14
Kent 13
Moscow 13
Bremen 11
Shanghai 9
Altamura 8
Fairfield 8
Helsinki 8
Lawrence 8
Seattle 8
Houston 7
New York 6
West Jordan 6
Buffalo 5
Princeton 5
Yubileyny 5
Boston 4
Lappeenranta 4
Los Angeles 4
Milan 4
Rome 4
Zurich 4
Campi Bisenzio 3
Como 3
Arezzo 2
Asciano 2
Boardman 2
Brussels 2
Cambridge 2
Catania 2
Colle di Val d'Elsa 2
Dallas 2
Frankfurt am Main 2
Jenera 2
Langhorne 2
London 2
Manchester 2
Monza 2
Palermo 2
Poggibonsi 2
Pune 2
Reggio Calabria 2
Romainville 2
Sant'Agata di Militello 2
Seoul 2
Shenzhen 2
Wenzhou 2
Zhengzhou 2
Ōtemachi 2
Agliana 1
Athens 1
Auckland 1
Beijing 1
Bitola 1
Chennai 1
Copenhagen 1
Dongyang 1
Easton 1
Fiesole 1
Fontebuona 1
Hamburg 1
Harbin 1
Hillsboro 1
Lisbon 1
Lucca 1
Medford 1
Osimo 1
Panama City 1
Pisa 1
Prague 1
Rio de Janeiro 1
Romola 1
San Diego 1
Soave 1
Sofia 1
St Louis 1
Suyicun 1
São Paulo 1
Toronto 1
Washington 1
Woodbridge 1
Totale 766
Nome #
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 81
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 81
Clinical, Neurophysiological, and Genetic Predictors of Recovery in Patients With Severe Acquired Brain Injuries (PRABI): A Study Protocol for a Longitudinal Observational Study 80
Predictors of Function, Activity, and Participation of Stroke Patients Undergoing Intensive Rehabilitation: A Multicenter Prospective Observational Study Protocol 76
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 69
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 66
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 66
null 63
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 62
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 61
Clinical, Neurophysiological, and Genetic Predictors of Recovery in Patients With Severe Acquired Brain Injuries (PRABI): A Study Protocol for a Longitudinal Observational Study 60
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 57
Plasma Neurofilament Light Chain as a noninvasive biomarker in neurodegenerative diseases 52
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 52
Intermediate alleles of HTT: A new pathway in longevity 51
The Huntington’s Disease Gene in an Italian Cohort of Patients with Bipolar Disorder 44
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol 43
GRN Missense Variants and Familial Alzheimer’s Disease: Two Case Reports 43
Parkinson-ALS with a novel MAPT variant 40
Putative novel CSF biomarkers of Alzheimer’s disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort 39
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 38
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 38
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum? 36
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 36
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 33
Sex influences clinical phenotype in valosin-containing protein mutations: A case family report and systematic literature review 32
Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation 28
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 16
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia 12
Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment 11
null 6
Totale 1.472
Categoria #
all - tutte 7.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.209


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 6 0 0 2
2021/202236 1 6 0 2 0 1 0 6 1 2 6 11
2022/2023261 25 42 20 23 22 39 31 12 36 0 11 0
2023/2024242 6 11 17 10 19 23 29 53 6 30 20 18
2024/2025925 58 168 106 264 329 0 0 0 0 0 0 0
Totale 1.472